Sara Dall'Armellina

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Prostate Cancer

Chronic Myeloid Leukemia

Renal Cell Carcinoma

Top Venues

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Roberto C Delgado Bolton, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Roberto C Delgado Bolton, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Guido Rovera, Serena Grimaldi, Sara Dall'Armellina, Michela Zotta, Monica Finessi, Roberto Passera, Désirée Deandreis
Comparison of Digital versus Analog 68 Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment. Diagnostics (Basel, Switzerland) 13 (23) (2023)
Alessio Rizzo, Sara Dall'Armellina, Daniele Antonio Pizzuto, Germano Perotti, Luca Zagaria, Valerio Lanni, Giorgio Treglia, Manuela Racca, Salvatore Annunziata
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? Cancers 14 (16) (2022)
Guido Rovera, Serena Grimaldi, Sara Dall'Armellina, Roberto Passera, Marco Oderda, Giuseppe Carlo Iorio, Alessia Guarneri, Paolo Gontero, Umberto Ricardi, Desiree' Deandreis
Predictors of Bone Metastases at 68 Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence. Diagnostics (Basel, Switzerland) 12 (6) (2022)